GLP-1 Receptor Pharmacology: A Researcher's Primer

The GLP-1 receptor is a class B (secretin family) G-protein-coupled receptor expressed in pancreatic beta cells, the central nervous system, and several peripheral tissues. Its primary intracellular signal is cAMP elevation via Gαs coupling.

Class B GPCRs have a distinct two-domain binding mechanism: the peptide N-terminus engages the transmembrane core, while the C-terminus binds the extracellular domain. This explains why N-terminal modifications dramatically alter agonist potency, while C-terminal modifications primarily extend half-life.

For in vitro pharmacology, the gold-standard assay is cAMP accumulation in HEK293 cells stably expressing human GLP-1R. EC50 values for native GLP-1 typically fall in the 10–100 pM range; the lipidated long-acting analogs sit in the same range but with vastly extended exposure time.

Bias signaling is an active area. Some analogs preferentially recruit β-arrestin pathways over Gαs, which may alter receptor internalization and downstream metabolic effects in cell-culture models.